Invenomic Capital Management LP Reduces Stock Holdings in Universal Health Services, Inc. (NYSE:UHS)

Invenomic Capital Management LP reduced its position in shares of Universal Health Services, Inc. (NYSE:UHSFree Report) by 62.6% in the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 44,523 shares of the health services provider’s stock after selling 74,651 shares during the period. Invenomic Capital Management LP’s holdings in Universal Health Services were worth $6,787,000 at the end of the most recent quarter.

Other institutional investors and hedge funds also recently bought and sold shares of the company. GAMMA Investing LLC purchased a new position in shares of Universal Health Services during the 4th quarter worth $42,000. Tompkins Financial Corp purchased a new position in Universal Health Services during the fourth quarter worth about $96,000. Van ECK Associates Corp increased its position in shares of Universal Health Services by 9.6% during the third quarter. Van ECK Associates Corp now owns 1,004 shares of the health services provider’s stock valued at $126,000 after acquiring an additional 88 shares during the last quarter. Parallel Advisors LLC raised its stake in shares of Universal Health Services by 11.3% in the 4th quarter. Parallel Advisors LLC now owns 1,161 shares of the health services provider’s stock valued at $177,000 after acquiring an additional 118 shares during the period. Finally, V Square Quantitative Management LLC acquired a new position in shares of Universal Health Services in the 3rd quarter worth approximately $175,000. 86.05% of the stock is currently owned by institutional investors and hedge funds.

Universal Health Services Stock Up 0.7 %

UHS opened at $188.93 on Tuesday. Universal Health Services, Inc. has a one year low of $119.90 and a one year high of $190.49. The company has a debt-to-equity ratio of 0.75, a quick ratio of 1.28 and a current ratio of 1.38. The stock has a market capitalization of $12.65 billion, a P/E ratio of 16.01, a price-to-earnings-growth ratio of 0.92 and a beta of 1.29. The business’s 50-day simple moving average is $173.94 and its 200-day simple moving average is $164.54.

Universal Health Services (NYSE:UHSGet Free Report) last released its quarterly earnings results on Wednesday, April 24th. The health services provider reported $3.70 EPS for the quarter, topping the consensus estimate of $3.14 by $0.56. The company had revenue of $3.84 billion for the quarter, compared to analyst estimates of $3.78 billion. Universal Health Services had a return on equity of 13.34% and a net margin of 5.57%. The firm’s revenue was up 10.8% compared to the same quarter last year. During the same quarter in the previous year, the company posted $2.34 earnings per share. Analysts anticipate that Universal Health Services, Inc. will post 13.76 EPS for the current year.

Universal Health Services Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Monday, June 17th. Investors of record on Monday, June 3rd will be given a $0.20 dividend. The ex-dividend date is Monday, June 3rd. This represents a $0.80 annualized dividend and a yield of 0.42%. Universal Health Services’s dividend payout ratio (DPR) is 6.78%.

Analyst Upgrades and Downgrades

UHS has been the topic of a number of research analyst reports. TD Cowen boosted their target price on Universal Health Services from $181.00 to $183.00 and gave the company a “hold” rating in a research report on Tuesday, April 30th. Baird R W upgraded Universal Health Services to a “hold” rating in a report on Thursday, May 30th. UBS Group upgraded shares of Universal Health Services from a “neutral” rating to a “buy” rating and boosted their price target for the stock from $189.00 to $226.00 in a research note on Monday, May 20th. Wells Fargo & Company raised their price objective on shares of Universal Health Services from $195.00 to $200.00 and gave the company an “overweight” rating in a research note on Thursday, March 28th. Finally, Barclays increased their target price on shares of Universal Health Services from $181.00 to $189.00 and gave the stock an “equal weight” rating in a report on Friday, April 26th. One research analyst has rated the stock with a sell rating, seven have issued a hold rating, six have assigned a buy rating and one has assigned a strong buy rating to the stock. Based on data from MarketBeat, the stock has an average rating of “Hold” and a consensus price target of $190.43.

Read Our Latest Research Report on UHS

Universal Health Services Company Profile

(Free Report)

Universal Health Services, Inc, through its subsidiaries, owns and operates acute care hospitals, and outpatient and behavioral health care facilities. It operates through Acute Care Hospital Services and Behavioral Health Care Services segments. The company's hospitals offer general and specialty surgery, internal medicine, obstetrics, emergency room care, radiology, oncology, diagnostic and coronary care, pediatric services, pharmacy services, and/or behavioral health services.

Recommended Stories

Want to see what other hedge funds are holding UHS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Universal Health Services, Inc. (NYSE:UHSFree Report).

Institutional Ownership by Quarter for Universal Health Services (NYSE:UHS)

Receive News & Ratings for Universal Health Services Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Universal Health Services and related companies with MarketBeat.com's FREE daily email newsletter.